Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer

Schmitz-Draeger, Bernd J.; Todenhoefer, Tilman; van Rhijn, Bas; Pesch, Beate; Hudson, Mliss A.; Chandra, Ashish; Ingersoll, Molly A.; Kassouf, Wassim; Palou, Joan; Taylor, John; Vlahou, Antonia; Behrens, Thomas; Critelli, Rossana; Grossman, H. Barton; Sanchez-Carbayo, Marta; Kamat, Ashish

dc.contributor.author	Todenhöfer, Tilman Wolfgang
dc.date.accessioned	2015-03-02T15:54:12Z
dc.date.available	2015-03-02T15:54:12Z
dc.date.issued	2014
dc.identifier.issn	1078-1439
dc.identifier.uri	http://hdl.handle.net/10900/59862
dc.language.iso	en	en
dc.publisher	Elsevier Science Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.urolonc.2013.10.010	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer	de_DE
dc.type	Article	de_DE
dc.type	ConferenceObject	de_DE
utue.quellen.id	20150115224006_00568	de_DE
utue.publikation.seiten	1061-1068	de_DE
utue.personen.roh	Schmitz-Draeger, Bernd J.
utue.personen.roh	Todenhoefer, Tilman
utue.personen.roh	van Rhijn, Bas
utue.personen.roh	Pesch, Beate
utue.personen.roh	Hudson, Mliss A.
utue.personen.roh	Chandra, Ashish
utue.personen.roh	Ingersoll, Molly A.
utue.personen.roh	Kassouf, Wassim
utue.personen.roh	Palou, Joan
utue.personen.roh	Taylor, John
utue.personen.roh	Vlahou, Antonia
utue.personen.roh	Behrens, Thomas
utue.personen.roh	Critelli, Rossana
utue.personen.roh	Grossman, H. Barton
utue.personen.roh	Sanchez-Carbayo, Marta
utue.personen.roh	Kamat, Ashish
dcterms.isPartOf.ZSTitelID	Urologic Oncology - Seminars and Original Investigations	de_DE
dcterms.isPartOf.ZS-Issue	7	de_DE
dcterms.isPartOf.ZS-Volume	32	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE